VitaNova Life Sciences Corporation: 10-K filed 2022-05-16

Name: VitaNova Life Sciences Corporation: 10-K filed 2022-05-16
Creator: VitaNova Life Sciences Corporation

What VitaNova Life Sciences Corporation reported in its annual report filed 2022-05-16 (fiscal FY 2022): 26 published measures, 54 facts as tagged in accession 0001683168-22-003645.

This filing

Form: 10-K (annual report)
Filed: 2022-05-16
Fiscal period: fiscal FY 2022
Accession: 0001683168-22-003645 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VitaNova Life Sciences Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-04-30	23,103	USD
At 2021-04-30	0	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-04-30	58,091	USD
At 2021-04-30	174,670	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-04-30	-34,988	USD
At 2021-04-30	-174,670	USD
At 2020-04-30	-122,576	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-04-30	23,103	USD
At 2021-04-30	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	139,682	USD	365
2020-05-01 to 2021-04-30	-52,094	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	4,061	USD	365
2020-05-01 to 2021-04-30	-42,286	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	120,000	USD	365
2020-05-01 to 2021-04-30	0	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	19,042	USD	365
2020-05-01 to 2021-04-30	42,286	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-04-30	-99,683	USD
At 2021-04-30	-239,365	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	5,871,250	shares	365
2020-05-01 to 2021-04-30	5,871,250	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	5,871,250	shares	365
2020-05-01 to 2021-04-30	5,871,250	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	0.02	USD/shares	365
2020-05-01 to 2021-04-30	-0.01	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	0.02	USD/shares	365
2020-05-01 to 2021-04-30	-0.01	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	0	USD	365
2020-05-01 to 2021-04-30	0	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	-13,367	USD	365
2020-05-01 to 2021-04-30	-52,094	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-04-30	23,103	USD
At 2021-04-30	0	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-04-30	58,091	USD
At 2021-04-30	174,670	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	133,367	USD	365
2020-05-01 to 2021-04-30	52,094	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-04-30	5,871,250	shares
At 2021-04-30	5,871,250	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2022-04-30	23,103	USD
At 2021-04-30	0	USD
At 2020-04-30	0	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-04-30	58,824	USD
At 2021-04-30	58,824	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2022-04-30	0	USD
At 2021-04-30	0	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	139,682	USD	365
2020-05-01 to 2021-04-30	-52,094	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	133,367	USD	365
2020-05-01 to 2021-04-30	52,094	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	0	USD	365
2020-05-01 to 2021-04-30	0	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2021-05-01 to 2022-04-30	0	USD	365
2020-05-01 to 2021-04-30	0	USD	365

Inspect the source

Entity: VitaNova Life Sciences Corporation / CIK 0001699709
Captured: 2026-09-21T17:23:55.214Z
SEC response SHA-256: cbbc169c744671a8d8af3ef9e33d6f01a860c1244f31147d1b245c430a85543c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001699709.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))